M2-Polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma

被引:149
|
作者
Zhang, Bicheng [1 ]
Yao, Guoqing [1 ]
Zhang, Yafei [1 ,2 ]
Gao, Juan [3 ]
Yang, Bo [1 ]
Rao, Zhiguo [1 ]
Gao, Jianfei [1 ]
机构
[1] Wuhan Gen Hosp, Guangzhou Command, Peoples Liberat Army, Dept Oncol, Wuhan, Hubei Province, Peoples R China
[2] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China
[3] Wuhan Gen Hosp, Guangzhou Command, Dept Gastroenterol, Peoples Liberat Army, Wuhan, Hubei Province, Peoples R China
关键词
M2-polarized macrophages; Tumor-associated macrophages; Lymphangiogenesis; Lung adenocarcinoma; Prognosis; CANCER; ACTIVATION; PHENOTYPE; CELLS; SURVIVAL; POLARIZATION; PROGRESSION; METASTASIS; POPULATION; EXPRESSION;
D O I
10.1590/S1807-59322011001100006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Tumor-associated macrophages have been implicated in promoting tumor growth, progression and metastasis. However, the activated phenotype (M1 or M2) of tumor-associated macrophages remains unknown in solid tumors. Therefore, this study examined the density and prognostic significance of M2-polarized tumor-associated macrophages in lung adenocarcinoma. METHODS: Tumor specimens from 65 lung adenocarcinoma patients were assessed by ELISA for Th1/Th2 cytokine concentrations. The activated phenotype (M1 or M2) of tumor-associated macrophages was determined utilizing immunofluorescence staining. Additionally, to evaluate lymphangiogenesis, peritumoral lymphatic microvessel density was measured using D2-40. The correlation between tumor-associated macrophage subtype and overall patient survival was analyzed using the Kaplan-Meier method and compared using the log-rank test. RESULTS: A shift toward Th2 cytokine expression was detected within lung adenocarcinoma microenvironments. Approximately 79.71 +/- 16.27% of tumor-associated macrophages were M2 polarized; the remaining 20.35 +/- 5.31% were M1 polarized. The infiltration of M2-polarized macrophages was significantly associated with P-TNM staging and lymph node metastasis. The peritumoral lymphatic microvessel density was significantly higher in the high M2-polarized tumor-associated macrophage group than in the low M2-polarized tumor-associated macrophage group. A significant difference in overall patient survival was detected not only between patients with tumors with high and low macrophage counts but also between patients with tumors with high and low counts of M2-polarized macrophages. CONCLUSION: Tumor-associated macrophages in lung adenocarcinoma have an M2-polarized subtype and are associated with poor prognoses, perhaps resulting from accelerated lymphangiogenesis and lymph node metastasis.
引用
收藏
页码:1879 / 1886
页数:8
相关论文
共 50 条
  • [21] Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma
    Yin, Ji-Zhong
    Shi, Xiao-Qian
    Wang, Ming-Dong
    Du, He
    Zhao, Xue-Wei
    Li, Bing
    Yang, Meng-Hang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 117
  • [22] Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinoma
    Thielmann, Carl Maximilian
    da Silva, Milene Costa
    Muley, Thomas
    Meister, Michael
    Herpel, Esther
    Muckenthaler, Martina U.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition
    Xiong, Cheng
    Zhu, Youwei
    Xue, Meilin
    Jiang, Yongsheng
    Zhong, Yiming
    Jiang, Lingxi
    Shi, Minmin
    Chen, Hao
    AGING-US, 2021, 13 (03): : 3386 - 3404
  • [24] Elevated SYNC Expression Is Associated with Gastric Tumorigenesis and Infiltration of M2-Polarized Macrophages in the Gastric Tumor Immune Microenvironment
    Wang, Dazhi
    Deng, Lihua
    Xu, Xiaona
    Ji, Yinghui
    Jiao, Zheng
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2021, 25 (03) : 236 - 246
  • [25] Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma
    Kuebler, Kirsten
    Ayub, Tiyasha H.
    Weber, Sarah K.
    Zivanovic, Oliver
    Abramian, Alina
    Keyver-Paik, Mignon-Denise
    Mallmann, Michael R.
    Kaiser, Christina
    Serce, Nuran Bektas
    Kuhn, Walther
    Rudlowski, Christian
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 176 - 183
  • [26] The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
    Ma, Junliang
    Liu, Lunxu
    Che, Guowei
    Yu, Nanbin
    Dai, Fuqiang
    You, Zongbing
    BMC CANCER, 2010, 10
  • [27] Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC
    Huang, Chengmei
    Ou, Ruizhang
    Chen, Xiaoning
    Zhang, Yaxin
    Li, Jiexi
    Liang, Yihao
    Zhu, Xiaohui
    Liu, Lei
    Li, Mingzhou
    Lin, Dagui
    Qiu, Junfeng
    Liu, Guanglong
    Zhang, Lingjie
    Wu, Yuanyuan
    Tang, Huiyi
    Liu, Yanmin
    Li Liang
    Ding, Yanqing
    Liao, Wenting
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [28] Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4
    Zhao, Peng
    Gao, Daiqing
    Wang, Qingjie
    Song, Bingfeng
    Shao, Qianqian
    Sun, Jintang
    Ji, Chunyan
    Li, Xingang
    Li, Peng
    Qu, Xun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2015, 12 (06) : 692 - 699
  • [29] Tumor-associated macrophages in lymphoma: From mechanisms to therapy
    Xiong, Xingfang
    Xie, Xiaoli
    Zhang, Yu
    Wang, Lijuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 112
  • [30] Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression
    Wang, Rui
    Zhang, Jie
    Chen, Sufeng
    Lu, Meng
    Luo, Xiaoyang
    Yao, Shihua
    Liu, Shilei
    Qin, Ying
    Chen, Haiquan
    LUNG CANCER, 2011, 74 (02) : 188 - 196